156 related articles for article (PubMed ID: 35236620)
1. Number of prostate-specific antigen (PSA) screening tests in the last five years reported by men in the United States in 2010, 2015, and 2018.
Richards TB; Dai S; Gray SC; Hall IJ; Siegel DA
Urol Oncol; 2022 May; 40(5):192.e19-192.e25. PubMed ID: 35236620
[TBL] [Abstract][Full Text] [Related]
2. National evidence on the use of shared decision making in prostate-specific antigen screening.
Han PK; Kobrin S; Breen N; Joseph DA; Li J; Frosch DL; Klabunde CN
Ann Fam Med; 2013; 11(4):306-14. PubMed ID: 23835816
[TBL] [Abstract][Full Text] [Related]
3. Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys.
Li J; Ding H; Richards TB; Martin I; Kobrin S; Marcus PM
J Am Board Fam Med; 2018; 31(4):658-662. PubMed ID: 29986994
[TBL] [Abstract][Full Text] [Related]
4. Temporal and Racial Trends in Prostate-specific Antigen Screening for U.S. Men With a Family History of Prostate Cancer.
Dalela D; Malchow T; Butaney M; Majdalany S; Corsi NJ; Rakic I; Sood A; Rogers C; Abdollah F
Urol Pract; 2023 Sep; 10(5):484-492. PubMed ID: 37347799
[TBL] [Abstract][Full Text] [Related]
5. Multilevel Small Area Estimation of Prostate-Specific Antigen Screening Test in the United States by Age Group: 2018 Behavioral Risk Factor Surveillance System.
Berkowitz Z; Zhang X; Richards TB; Sabatino SA; Peipins LA; Smith JL
J Am Board Fam Med; 2021; 34(3):634-647. PubMed ID: 34088823
[TBL] [Abstract][Full Text] [Related]
6. Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.
Fedewa SA; Gansler T; Smith R; Sauer AG; Wender R; Brawley OW; Jemal A
Ann Fam Med; 2018 Mar; 16(2):139-144. PubMed ID: 29531105
[TBL] [Abstract][Full Text] [Related]
7. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
[TBL] [Abstract][Full Text] [Related]
8. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
[TBL] [Abstract][Full Text] [Related]
9. Predictors of repeated PSA testing among black and white men from the Maryland Cancer Survey, 2006.
Zhu Y; Sorkin JD; Dwyer D; Groves C; Steinberger EK
Prev Chronic Dis; 2011 Sep; 8(5):A114. PubMed ID: 21843417
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in prostate-specific antigen-based prostate cancer screening: State-by-state and region-by-region analyses.
Jindal T; Kachroo N; Sammon J; Dalela D; Sood A; Vetterlein MW; Karabon P; Jeong W; Menon M; Trinh QD; Abdollah F
Urol Oncol; 2017 Jul; 35(7):460.e9-460.e20. PubMed ID: 28256311
[TBL] [Abstract][Full Text] [Related]
11. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
[TBL] [Abstract][Full Text] [Related]
12. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
[TBL] [Abstract][Full Text] [Related]
13. Five-year downstream outcomes following prostate-specific antigen screening in older men.
Walter LC; Fung KZ; Kirby KA; Shi Y; Espaldon R; O'Brien S; Freedland SJ; Powell AA; Hoffman RM
JAMA Intern Med; 2013 May; 173(10):866-73. PubMed ID: 23588999
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
15. Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.
Drazer MW; Huo D; Schonberg MA; Razmaria A; Eggener SE
J Clin Oncol; 2011 May; 29(13):1736-43. PubMed ID: 21444863
[TBL] [Abstract][Full Text] [Related]
16. Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening.
Leapman MS; Wang R; Park H; Yu JB; Sprenkle PC; Cooperberg MR; Gross CP; Ma X
JAMA Oncol; 2022 Jan; 8(1):41-47. PubMed ID: 34762100
[TBL] [Abstract][Full Text] [Related]
17. Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.
Li J; Zhao G; Hall IJ
Am J Prev Med; 2015 Aug; 49(2):259-63. PubMed ID: 25997905
[TBL] [Abstract][Full Text] [Related]
18. Lack of follow-up of prostate-specific antigen test results.
McFall SL; Smith DW
Public Health Rep; 2009; 124(5):718-25. PubMed ID: 19753950
[TBL] [Abstract][Full Text] [Related]
19. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.
Tawfik A
Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237
[TBL] [Abstract][Full Text] [Related]
20. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
